Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights. [PDF]
López-Castro R +6 more
europepmc +1 more source
[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. [PDF]
Marzo-Castillejo M +4 more
europepmc +1 more source
Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]
Vallejo JSA +7 more
europepmc +1 more source
Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity. [PDF]
Cerbone L +16 more
europepmc +1 more source
[Cardiac metastasis of renal carcinoma in the absence of invasion of the inferior vena cava: case report]. [PDF]
Scatularo CE +3 more
europepmc +1 more source
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. [PDF]
Guazzelli A +6 more
europepmc +1 more source
Incidental finding of an ectopic b2 thymoma attached to the pericardium. [PDF]
Endara SA +4 more
europepmc +1 more source
Mesoteliomas pleurais malignos.
L Carreiro +4 more
openaire +1 more source
[Gemcitabine-induced digital necrosis in a patient with cervical squamous cell carcinoma: case report and literature review]. [PDF]
Guarín-Rivera S +4 more
europepmc +1 more source

